Point-of-care testing companies develop and manufacture diagnostic tests designed for use at or near the patient, rather than relying on conventional central laboratories. These technologies support timely clinical decisions in hospitals, GP surgeries, pharmacies, ambulances, community care and some home-testing settings.
This category includes companies working on:
Browse 40 UK point-of-care testing companies below.
Rapid diagnostic platforms for infectious disease and consumer testing
Sapphiros is a privately held diagnostics portfolio company backed by KKR and Neoenta. UK operations include Biocrucible, a molecular diagnostics company developing ultra-rapid isothermal nucleic acid amplification assays, and an Extreme Volume Manufacturing capability producing lateral flow diagnostic tests at…
Multiplex nanophotonic blood testing platform for point-of-care diagnostics
Attomarker is a developer of point-of-care multiplex diagnostic devices using proprietary gold nanoparticle nanophotonic technology. Its platform measures up to 20 biomarkers simultaneously from a single finger-prick blood sample, delivering quantitative results within minutes. Tests are UKCA-marked and in clinical…
Rapid light-based point-of-care diagnostics for infections and pathogens
ExGen Dx, previously Linear Diagnostics, is a University of Birmingham spin-out developing a portable, light-based diagnostic platform that detects multiple infections from a single sample without laboratory equipment. The technology combines a patented optical detection method with a room-temperature amplification…
Global IVD company specialising in point-of-care diagnostics and life sciences
EKF Diagnostics is an AIM-listed global in vitro diagnostics company headquartered in Penarth, near Cardiff. The group develops and manufactures point-of-care analysers for haemoglobin, HbA1c, glucose, lactate, and ketone measurement, alongside a central laboratory reagent and rapid test portfolio distributed to over…
Nanotechnology-based point-of-care cardiovascular diagnostics for decentralised healthcare
The NanoBioTechnology Hub is a Manchester-based developer of miniaturised point-of-care diagnostic devices using nanotechnology and biotechnology. The company is developing an ultra-sensitive handheld device for pre-hospital cardiovascular biomarker analysis, using lateral flow technology and biointerfaced…
Handheld blood-electrolyte monitoring technology for kidney and cardiovascular care
Kalium Health is a medical technology company developing handheld blood-electrolyte monitoring for people with kidney and cardiovascular conditions. Its device is designed to measure potassium and other electrolytes from a single drop of blood using disposable test consumables, supporting monitoring outside…
Portable PCR diagnostics for high-consequence infectious diseases
BioGene develops portable real-time PCR instruments and diagnostic reagents for detecting infectious pathogens. Its extraction-free, freeze-dried chemistry is designed to detect pathogens directly from crude samples in under 30 minutes, reducing the need for conventional laboratory preparation. The company's assays…
Plasmonic PCR diagnostics for rapid infectious disease detection
RapidX Bio is a biotechnology company developing point-of-care molecular diagnostics for infectious diseases. Its plasmonic PCR technology uses light-responsive gold nanorods to accelerate nucleic acid amplification and reduce sample preparation requirements. The company is developing portable tests to identify…
Active protease biomarker assays for respiratory disease diagnostics
ProAxsis is a diagnostics company developing and supplying laboratory immunoassays and point-of-care tests for the measurement of active protease biomarkers in respiratory disease. Using patented activity-based capture technology, the company's assays quantify neutrophil elastase and proteinase 3 as indicators of…
Ultra-fast PCR point-of-care diagnostics from swab to result
LEX Diagnostics is a molecular diagnostics company developing rapid point-of-care PCR testing through its proprietary thermal cycling platform. Its system delivers quantitative PCR results directly from a dry swab in six to ten minutes with no sample preparation, targeting respiratory infections including influenza…
Single-molecule fluorescence platform for rapid point-of-care pathogen detection
Pictura Bio is a medical technology company developing a rapid diagnostic platform that combines single-molecule fluorescent microscopy with deep learning to identify pathogens in clinical samples in under one minute. The platform uses a universal fluorescent label and a trained AI model to detect any known pathogen…
Rapid point-of-care antibiotic susceptibility testing for antimicrobial resistance
Microplate Dx is a diagnostics biotechnology company developing a rapid antibiotic susceptibility testing platform for use at the point of care. Its biosensor technology uses hydrogel-modified electrodes loaded with antibiotics to determine the most effective treatment for a patient's bacterial infection in under one…
Point-of-care molecular diagnostic platform for rapid infectious disease detection
Diagnostics for the Real World (Europe) is a Cambridge University spin-out developing and commercialising a fully automated point-of-care molecular diagnostic system for rapid detection of infectious diseases. Using isothermal nucleic acid amplification, the platform delivers sample-in-result-out testing without…
Rapid point-of-care molecular diagnostics for infectious disease
Llusern Scientific is a diagnostics company developing portable, rapid molecular diagnostic systems for use at the point of care. Using isothermal amplification technology, the company's platform identifies bacterial pathogens directly from patient samples without laboratory infrastructure, delivering results within…
Point-of-care pharmacogenetic testing platform for emergency healthcare
Genedrive is a molecular diagnostics company developing point-of-need pharmacogenetic tests that identify genetic variants to guide safer, more personalised medicine decisions in time-critical emergency care. Its flagship products, developed and validated with NHS partners, include a neonatal test preventing…
Lateral flow rapid test development, manufacturing and regulatory services
Abingdon Health is a contract development and manufacturing organisation specialising in lateral flow rapid diagnostic tests. It provides end-to-end services spanning assay development, scale-up manufacturing, regulatory approval and commercialisation support across healthcare, animal health and plant health. The…
Point-of-care HPV self-testing for cervical cancer screening
10zyme is an early-stage medical technology company developing a point-of-care self-test for high-risk human papillomavirus, integrating synthetic biology with machine learning to deliver instant results without laboratory processing. Its test screens for all 14 high-risk HPV types linked to cervical cancer,…
Enzyme-free multiplex RNA diagnostics for rapid clinical decisions
Cambridge Nucleomics is a biotechnology company developing a proprietary nanopore-based platform for rapid, high-multiplexed detection of nucleic acid biomarkers. Its enzyme-free soluble nanoarray technology enables simultaneous quantification of up to 200 RNA and DNA targets from low-input samples within one hour.…
Polymer-based rapid diagnostic technology for bacterial and fungal infections
Molecular Titans is a University of Bradford spin-out developing a patented polymer nanotechnology platform for rapid infection diagnosis. Its thermoresponsive polymers bind selectively to bacterial and fungal pathogens, producing a measurable signal within minutes rather than days. Initial applications include…
Rapid point-of-care molecular testing for sexually transmitted infections
Binx Health is a diagnostics company that develops and manufactures a rapid point-of-care molecular testing platform for sexually transmitted infections. Its benchtop instrument and single-use cartridges detect the genetic material of chlamydia and gonorrhoea from patient samples in around 30 minutes, allowing…